Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Park Place Capital Corp

Park Place Capital Corp decreased its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 19.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 755 shares of the business services provider’s stock after selling 186 shares during the period. Park Place Capital Corp’s holdings in Exponent were worth $67,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Barclays PLC boosted its holdings in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock worth $11,127,000 after buying an additional 66,263 shares in the last quarter. Geneva Capital Management LLC raised its position in Exponent by 1.7% during the third quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after acquiring an additional 27,339 shares in the last quarter. Renaissance Technologies LLC bought a new stake in Exponent in the second quarter worth $3,215,000. American Century Companies Inc. increased its holdings in shares of Exponent by 201.5% during the 2nd quarter. American Century Companies Inc. now owns 33,833 shares of the business services provider’s stock valued at $3,218,000 after acquiring an additional 22,611 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Insider Buying and Selling at Exponent

In related news, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the transaction, the director now directly owns 5,871 shares in the company, valued at $565,494.72. This represents a 15.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Paul R. Johnston sold 14,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the transaction, the director now directly owns 80,742 shares in the company, valued at $8,445,613.20. The trade was a 14.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,339 shares of company stock valued at $3,103,065 in the last 90 days. 2.10% of the stock is currently owned by company insiders.

Exponent Stock Down 1.1 %

Shares of NASDAQ:EXPO opened at $92.94 on Thursday. The business has a 50 day moving average price of $93.33 and a 200 day moving average price of $101.46. The company has a market cap of $4.72 billion, a price-to-earnings ratio of 44.90 and a beta of 0.71. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.